Given the dynamic variability and heterogeneity of CD5 expression and its link to the proliferative pool of neoplastic cells, we aimed to further characterize the chemokine and adhesion molecule profile of CD5high and CD5low neoplastic clones using the novel CD5/CD19 model in peripheral blood of CLL patients. Here, CD5 is linked to B-cell chronic lymphocytic leukemia.